Joshua Hill, MD

Financial relationships

  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Allogene
    Topic:
    infectious disease
    Date added:
    11/04/2022
    Date updated:
    11/04/2022
    Relationship end date:
    03/09/2021
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Allovir
    Topic:
    infectious disease
    Date added:
    11/04/2022
    Date updated:
    11/04/2022
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Allovir
    Topic:
    infectious disease
    Date added:
    11/04/2022
    Date updated:
    11/04/2022
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Takeda
    Topic:
    infectious disease
    Date added:
    11/04/2022
    Date updated:
    11/04/2022
    Relationship end date:
    11/23/2020
  • Attribution:
    Self
    Type of financial relationship:
    Grant Or Contract
    Ineligible company:
    Takeda
    Topic:
    infectious disease
    Date added:
    11/04/2022
    Date updated:
    11/04/2022
    Relationship end date:
    07/01/2021
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    CRISPR
    Topic:
    infectious disease
    Date added:
    11/04/2022
    Date updated:
    11/04/2022
    Relationship end date:
    11/17/2020
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Octapharma AG
    Topic:
    infectious disease
    Date added:
    11/04/2022
    Date updated:
    11/04/2022
    Relationship end date:
    06/14/2021
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    OptumHealth
    Topic:
    infectious disease
    Date added:
    11/04/2022
    Date updated:
    11/04/2022
    Relationship end date:
    05/06/2021
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    SymBio
    Topic:
    infectious disease
    Date added:
    11/04/2022
    Date updated:
    11/04/2022
  • Attribution:
    Self
    Type of financial relationship:
    Independent contractor
    Ineligible company:
    Karius
    Topic:
    infectious disease
    Date added:
    11/04/2022
    Date updated:
    11/04/2022

Pages

Return to 122 Infectious Diseases and Geographic Medicine Division Grand Rounds: "Infectious Complications of CAR-T Cell Therapies: A Paradigm on the Move" (111022)

 

**Disclaimer**

This Continuing Medical Education (CME) Learning Management System, Ethos, includes individuals designated as 'faculty' for CME purposes. Please note that the term 'faculty' refers solely to their role as a contributor/planner within a CME activity and does not imply any formal affiliation with UT Southwestern Medical Center (UTSW). The display of names and credentials is intended for educational purposes only and does not necessarily indicate a professional or academic relationship with UTSW. Participants are encouraged to verify the affiliations and credentials of faculty members independently if further clarification is needed.